NewsFobi Signs Marketing Deal with Abbot’s Butcher, A Premium US Plant-Based Protein Company28 Jan 2022
TechnologyEurope’s Publishers Call for GDPR Challenges to Be Addressed Urgently on Data Protection Day28 Jan 2022
AmericasProMIS Neurosciences Appoints Internationally Recognized Neuroscientist Dr. Cheryl Wellington to Its Scientific Advisory Board27 Jan 2022
NewsUsing Smart Sensors and Cloud-Based Analytics, Canary’s 20-Minute Handheld COVID-19 Saliva-Based Molecular Test with PCR Quality Results Achieves CE Mark26 Jan 2022
NewsFobi Integrates With Square, Offering Real-Time Data Analytics to Retailers Around the Globe25 Jan 2022
NewsPurpose ESG Names Former CEO of DaimlerChrysler Canada as Chairman of the Board of Directors18 Jan 2022
NewsRockridge Resources Reports 4.06% and 1.60% Copper in Grab Samples and Identifies New Target West of Gilbert Lake at Its Knife Lake Project18 Jan 2022
NewsProMIS Neurosciences Announces Antibody Program for Schizophrenia Therapy and Recruitment of Dr. Carsten Korth to Its Scientific Advisory Board18 Jan 2022
NewsSkyharbour’s Partner Company Azincourt Energy Provides Update on Camp Construction and Drill Mobilization at East Preston Uranium Project, Saskatchewan13 Jan 2022
NewsFOBI Announces Definitive Agreement To Acquire Passworks S.A. For €400,000 To Further Expand FOBI's Global Digital Wallet Pass Portfolio13 Jan 2022
HealthNew Global Coalition Launches Initiative to Secure a Rescheduling of Psilocybin Under the 1971 UN Convention on Psychotropic Substances13 Jan 2022
NewsProMIS Neurosciences to Participate in the Biotech Showcase 2022 Virtual Panel Discussion: Aduhelm Stimulating the Next Generation of Alzheimer’s Treatment7 Jan 2022
